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The influence of specific pretreatment variables (i.e., age, gender, birth order, number of 
children in the family, and family history of enuresis) on outpatient urine alarm treatment 
outcomes was examined.  A total of 186 Israeli children between the ages of 4 to 7 
participated in the study, and of those, 55 children were 4 years old. The entire sample 
was used to test the age-related pretreated variable, and all other pretreatment variables 
were solely analyzed using the sample of 4-year-old children at the time of treatment. 
The data were derived from two different sources: (a) treatment files from a clinical 
psychologist, and (b) a six question telephone survey.   Statistical analysis revealed 
evidence that family history is a positive predictor of urine treatment outcomes in young 
children. For young children with a family history of bedwetting, 71.9% were dry post- 
treatment, while only 43.5% of young children without a family history of bedwetting 
were dry post-treatment. Other statistical analysis showed no evidence (p > .05) of 
pretreatment variables’ (i.e., age, gender, birth-order, and number of children in the 
family) influence on urine alarm treatment outcomes in young children.  The findings 
indicate that, in young children, a family history of bedwetting is a positive predicator for 
urine alarm treatment outcomes. Pediatricians and other pediatric health practitioners are 
encouraged to treat young children with a family history of bedwetting with a urine alarm 
treatment approach. 
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Enuresis, more familiarly referred to as bedwetting, is one of the most widespread 
(Nappo et al., 2002; Rogers, 2002) and chronic childhood disorders affecting 7% to 22 % 
children by age seven (Butler & Holland, 2000). Boys are more affected by this disorder 
than girls of the same age. The cause of enuresis is variously understood as being 
multifaceted and multi-factorial (El-Radhi, 2005; Thiedke, 2003). Sources of causation 
for enuresis development include a low level of the antidiuretic hormone (ADH) 
vasopressin (Butler, 1994), reduction in functional bladder capacity (Kawauchi et al., 
2003; Yeung, Chiu, & Sit, 1999), lack of sleep arousal (Neveus, 2003; Wolfish, 1999), 
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genetic factors (Eiberg, Berendt, & Mohr, 1995; Von Gontard, Hollmann, Rittig, & 
Lehmkul, 1997; Von Gontard, Eiberg, Hollmann, Rittig, & Lehmkuhl, 1998; Von 
Gontard, Eiberg, Hollmann, Rittig, & Lehmkuhl, 1999), delayed maturation (Fergusson, 
Horwood, & Shannon, 1986; Fritz et al., 2004), and psychological factors (Hagglof, 
Andren, Bergstrom,  Marklund, & Wendelius, 1998; Theunis, Van Hoecke, Paesbrugge, 
Hoebeke, & Vander Walle, 2002). 
Several treatment options are available for addressing bedwetting symptoms, 
including pharmacology, alternative therapies, and behavioral interventions with or 
without using a urine alarm system. To date, the urine alarm system remains the superior 
treatment modality for bedwetting symptoms (Boris, & Dalton, 2004; Houts, Berman, & 
Abramson, 1994) with successful outcome rates ranging between 65%-75% (Butler & 
Glasson, 2005). In the past, different outcome predicting pretreatment (OPP) variables for 
urine  alarm  treatment  have  been  established  (e.g.,  severity  of  wetting  episodes, 
concurrent daytime wetting episodes, family stress, and lack of motivation) (Butler & 
Robinson, 2002). OPP variables can be instrumental in identifying existing conditions 
that either support or hinder urine alarm treatment (Moffat & Cheang, 1995), thus making 
OPP variables valuable from a clinical as well as a research perspective. 
Earlier studies have been conducted on OPP variables (Butler, Redfern, & 
Forsythe, 1990; Butler & Robinson, 2002; Devlin & O’Cathain, 1990; Dische, Yule, 
Corbett,  &  Hand,  1983;  Fielding,  1985).  Comparing  the  results  of  these  studies  is 
complex because most studies vary significantly in outcome measures and age of study 
participants. Overall, in the cited studies, the age of the study participants varied from age 
4.8 to age 17 and outcome measures to establish dryness varied from 14 consecutive 
nights to 6 weeks of consecutive dryness, with most studies defining initial treatment 
success at 14 consecutive dry nights (Butler et al., 1990; Butler & Robinson, 2002; 
Fielding, 1985), while other studies define treatment success as 21 consecutive dry nights 
during the treatment followed by 21 consecutive nights post treatment (Dische et al., 
1983), or 42 consecutive dry nights (Devlin & O’Cathain, 1990). 
In the 1980s, Dische and associates (1983) and Fielding (1985) researched 
different variables associated with treatment outcome for alarm treatment. Dische’s et al. 
(1983) study included 113 children ranging in age from 4.8 to 13.2 years. Pretreatment 
factors related to treatment outcome included age, gender, birth order, family size, social 
class, child’s behavior rated by a parent, child’s behavior rated by a teacher, previous 
treatment for enuresis, secondary or primary enuresis, presence of urinary infection, 
diurnal   wetting   episodes,   encopresis,   family   difficulties,   unsatisfactory   housing 
conditions, and severe financial hardship. The results of the study indicated only two 
OPP variables-unsatisfactory housing conditions and family difficulties–had an adverse 
effect on initial treatment success, while relapse and long term treatment outcomes were 
adversely influenced by deviant behavior scores on the teacher rating scale and family 
difficulties. All other tested pretreatment variables were found unrelated to treatment 
outcome. 
Fielding (1985) studied pretreatment variables associated with enuresis treatment 
failure.   The study accepted 52 children ranging in age from 5 to 17 years. Thirty 
different pretreatment variables, including variables deriving from socio-demographic 
data, enuresis history, family history of enuresis, social background, and behavioral 
problems,  were  researched.  The  findings  indicated  that  only  three  variables  had  an 
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adverse effect on initial treatment outcome, including frequency of micturition, urgency 
of micturition, and a previous experience with enuresis alarm treatment. 
Butler et al. (1990) investigated urine alarm treatment outcomes in 55 children 
ranging in age from 6.9 to 14.7 years. The researchers studied various pretreatment 
variables, including personal data, mother’s tolerance, willingness of the child to change, 
resistance to change, family reaction, and secrecy. Findings indicated that positive 
treatment outcome was associated with the child understanding enuresis psychologically 
and showing no resistance to change, while treatment success declined where there was 
evidence of resistance to change. Devlin and O’Cathain (1990) analyzed predicting 
variables for urine alarm treatment in 96 children ranging in age from age 6 to 17 years. 
For this study, four different categories of pretreatment variables were used (socio- 
demographic data, history of enuresis, data about possible physical/psychiatric disorders 
and family stress were analyzed), and findings indicated that three stress related 
pretreatment variables (i.e., family stress, little or no distress of the child about the 
bedwetting, and developmental delay in the child) had a negative influence on urine 
alarm treatment outcome. 
A third instructive study by Butler and Robinson (2002) analyzed pretreatment 
variables for enuresis alarm treatment in 66 children ranging in age from 6 to 16 years. 
Pretreatment variables included age, gender, severity of wetting, and functional bladder 
capacity.  In this study, only functional bladder capacity was identified as a negative 
predictor for enuresis alarm treatment outcome. 
In the reviewed studies, specific pretreatment variables, including age (Butler & 
Robinson, 2002; Butler et al., 1990; Dische et al., 1983; Devlin & O’Cathain, 1990; 
Fielding, 1985), gender (Butler & Robinson, 2002; Butler et al., 1990; Dische et al., 
1983; Devlin & O’Cathain, 1990; Fielding, 1985), birth order (Dische et al., 1983; Devlin 
&  O’Cathain,  1990;  Fielding,  1985),  family  size  (Dische  et  al.,  1983,  Devlin  & 
O’Cathain, 1990), or family history (Fielding, 1985) were found to be unrelated to 
enuresis alarm treatment outcomes. Based on this inconclusive history of enuresis 
research, questions arise regarding the identification of urine alarm pretreatment variables 
especially for younger children. Research that provides a degree of clarity on the nature 
of enuresis pretreatment variables can inform key aspects of the intervention process 
including family settings, parent understanding of the nature of enuresis, parent and 
parent-child   education   regarding   the   treatment   process   that   is   developmentally 
appropriate. It also can provide pediatricians and other pediatric health practitioners with 
tools to better prepare families for the treatment regiment and help set appropriate 
expectations for treatment outcomes. 
 
Focus of the Study 
This study focused on the analysis of interactions of five different OPP variables 
(i.e., gender, birth order, numbers of siblings in a family, family history of bedwetting, 
and age) and urine alarm treatment for 4-year-old children.  While the OPP variables 
gender, birth-order, numbers of siblings in a family, and family history of bedwetting 
were solely analyzed on the study sample of children age four, the OPP variable age was 
analyzed utilizing the entire study sample including children age four to seven. 
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Participants 
Method 
In this study, 400 bedwetting children, aged 4-7 years, and treated by a clinical 
psychologist in Israel, were randomly chosen to be included in the study sample. These 
children were randomly selected from a population pool of 948 bedwetting children 
under treatment at fourteen urine alarm treatment offices in Israel. Inclusion criteria for 
participation in the study was determined by the following criteria: each child started 
treatment between June 1, 2003 and May 31, 2004; the child was receiving or had 
received urine alarm treatment only (i.e., no additional medication was prescribed) during 
the initial treatment session; the child was at least 4 years of age and not older than 7 
years of age; the child was diagnosed with enuresis or the child was 4 years of age and 
met the criteria for enuresis described in the Diagnostic and Statistical Manual of Mental 
Disorders, (DSM-IV-TR; American Psychiatric Association [APA], 2000) with the 
exception of the age limit. 
Of the 400 potential study participants only 265 could be contacted and of those 
50 potential participants refused to participate in the study and 29 potential participants 
were excluded from the study for various reasons. Ultimately, the study sample was 
comprised of 186 participants, with 112 male participants and 74 female participants. 
Treatment 
All children received urine alarm treatment from the same clinical psychologist in 
one of the fourteen bedwetting clinics in Israel. Each child participated in a combined 
assessment and treatment session.  The initial session included diagnosis, a short and 
general education about the disorder, introduction to treatment, demonstration of the 
urine alarm device, explanation of the use of a daily progress chart, and discussion of 
arrangements for follow up. Follow-up treatment was made available in a face-to face 
format,  via  telephone  consultation,  or  review  and  response  to  fax,  letter,  or  e-mail 
inquires directed to the treating clinical psychologist. During follow-up sessions, progress 
was evaluated with the use of the daily progress chart combined with information from 
the child and the attending adult. When necessary, a multiple waking exercise was 
introduced with those children having difficulties waking up to the alarm. The treatment 
was considered to be successfully completed after the achievement of 21 consecutive dry 
nights.  Parents  were  instructed  to  monitor  the  child  for  relapse,  and  when  relapse 
occurred, to return to the office and restart the urine alarm treatment under clinical 
supervision. 
Procedure 
Data for this study originated from two sources: the treatment files of the clinical 
psychologist and from a telephone survey of the clients (i.e., parents of the children 
receiving treatment). Treatment file data was generated by the clinical psychologist who 
recorded   the   information   during   the   initial   assessment   and   treatment   session. 
Demographic data was also derived from this source and included: age of the child, 
gender, birth order, the family history of bedwetting symptoms [mother, father, sibling, 
uncle, aunt, grandparent having suffered (or are currently suffering) from bedwetting 
symptoms], and information about prescribed medication (e.g., Minirine or Elatrolet) 
used during the urine alarm treatment. 
The second data source was derived using a telephone survey methodology. A 
survey was constructed that consisted of six questions inquiring about the number of 
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wetting episodes during the last month, supplementary enuresis medication, and possible 
additional enuresis treatment. 
The telephone survey items were reviewed and subsequently revised by three 
clinical psychologists experienced in treating enuretic children with the urine alarm 
method in Israel to ensure the content validity of the instrument (Sproull, 2002). In 
addition, a pilot telephone survey was conducted using the survey instrument with 20 
children to ensure that the text of the survey reflected content validity (i.e., it was easy to 
understand and used simple to follow questions). Following analysis of the pilot study 
data and completion of survey instrument revision, the study was implemented in spring 
of 2005. 
The telephone survey was conducted by an agency specialized in data collection, 
and the data collection was supervised by the treating clinical psychologist. The 
interviewers made a maximum of four attempts to reach a parent of each study subject. 
Data derived from the telephone survey included: treatment success (defined by less than 
three wetting episodes during the previous month), treatment failure (defined by three or 
more wetting episodes during the previous month), identification of medication taken to 
control  bedwetting  symptoms  during  urine  alarm  treatment,  and  whether  the  child 
received additional bedwetting treatment after the urine alarm treatment. 
Data Analysis 
Descriptive statistics were employed for analyzing the study population. One-way 
analysis of variance [ANOVA] was used to ascertain the success rate of the urine alarm 
treatment for the total study population. The data of the 4-year-olds was then extracted 
from the data pool, and an analysis of pretreatment variables for this population was 
undertaken using logistic regression (birth order, number of children in a family, genetic 
predisposition) to examine a possible relationship between each of these variables and 
treatment outcome. Further, age as a pretreatment variable was examined by comparing 
the relationship of treatment outcomes in children ages 4 to 7 using a chi-square test of 
independence and an analysis of variance. 
 
Results 
The pool of study participants totaled 186. This total was derived from an initial 
pool of 400 children randomly chosen for the study from the total population of 948 
children treated for enuresis. Children taking medication to control bedwetting symptoms 
such  as  Minirine,  Elatrolet,  or  any  other  medication  in  support  of  the  urine  alarm 
treatment were excluded from the study. From the 400 randomly chosen study 
participants, 135 could not be contacted via telephone and therefore were excluded from 
the study. A total of 265 children were contacted via the telephone survey.  Fifty declined 
participation, while 215 participants consented to participate. Of this derived number of 
215 participants, 29 were excluded for specific reasons (i.e., 21 were taking additional 
medication; 4 did not compete the questions; 2 did not start treatment; 2 were adopted 
children). 
Sample Description 
The mean age of the study participants (N = 186) was 5.5 years (M = 5.45, SD = 
1.15) with an age range from age 4 to age 7. Overall, 112 boys and 74 girls participated 
in the study, representing a male/female percentage ratio of 60/40. Participating children 
were largely first or second born children with 52.2% first born (n = 97), 31.2% second 
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born (n = 58), 11.3% third born (n = 21), 2.7% fourth born (n = 4) and 2.7% fifth born (n 
= 4). The children had an average of 1.5 siblings with 9.7 % (n = 18) of participating 
children having no siblings, 49.5% (n =92) of the children having one sibling, 26.5% (n = 
49) of the children having two siblings, 7.5% (n = 14) of the children having three 
siblings, 6.5% (n = 12) of the children having four siblings, and 0.5% (n = 1) of the 
children having seven siblings. Children from families with a history of bedwetting 
symptoms  totaled  123  (67%).  Post  treatment,  64.5%  (n  =  120)  of  the  participants 
achieved dryness, defined as not more than 0 to 2 wetting incidents in the last month, and 
35.5% (n = 66) participants wet their beds three or more times in a month, thus not 
achieving dryness. 
Subset sample description of 4-year-olds 
Fifty-five children age four were included for the analysis of pretreatment 
variables. Of those, 52% (n = 29) were male and 47.3% (n = 26) female. With reference 
to birth order, the majority of study participants in the group of 4–year-olds were first 
born (61.8%, n = 34), 29.1% (n = 16) second born children, 7.3% (n = 4) third born 
children, and 1.8% (n = 1) a fourth born child. Most children (56.4%, n = 31) had one 
sibling, while 16.3% (n = 9) had no sibling(s), 18.2% (n = 10) had two siblings, 7.3% (n 
= 4) had three siblings, and one study participant (1.8%, n = 1) had four siblings. Of the 
children in this age group, 58.2% (n = 32) had a family history of bedwetting, and 41.8% 
(n = 23) reported no family history. Children achieving dryness included 60% or 33 
children in this subset of 4 year-olds, while 40% (n = 22) children presented with 
bedwetting symptoms post treatment. 
Variables associated with treatment outcome in 4-year-olds 
Gender was found to have no influence on treatment outcome in children age four 
receiving enuresis alarm treatment. The group of 4-year-olds consisted of 52.7% (n =29) 
male participants and 47.3% (n =26) female participants. Post treatment, 34.5% (n = 19) 
boys and 25.5% (n =14) girls achieved dryness, while 18.2% (n =10) of the boys and 
21.8% (n = 12) of the girls still suffered from bedwetting. Logistical regression analysis 
was conduced with the treatment outcome as the dependent variable and gender as the 
independent variable. The logistic regression slope coefficient for gender was negative (B 
= -.488) indicating that girls were less likely to be dry post-treatment. However, results of 
the Wald statistic = .77, p = .38 showed that this slope coefficient was not statistically 
significant. 
Birth order is not a predicting variable for treatment outcome in 4-year-olds. 
Logistical regression analysis was conduced with the treatment outcome as the dependent 
variable and birth order as the independent variable. This group of 4-year-olds consisted 
of 61.8% (n =34) first born children, 29.1% (n =16) second born children, 7.3% (n =4) 
third born children and 1.8% (n =1) fourth born children. Of the first born children post 
treatment, 40% (n =22) achieved dryness, while 21.8% (n =12) continued to suffer from 
bedwetting. In the group of second born children, 16.4% (N =9) achieved dryness post 
treatment, while 12.7% (n =7) persisted with bedwetting symptoms. In the group of third 
born children, 3.7% (n =2) achieved dryness post treatment, while3.6% (n =2) did not. In 
the last group of fourth born children, none (n = 0) achieved dryness post treatment, 
while 1.8% (N =1) still suffered from bedwetting symptoms.  Overall, enuresis alarm 
treatment was most successful in first born children.  The logistic regression analysis 
indicted a negative (B = -.478) logistic regression slope coefficient for birth order in 
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children age 4, suggesting that latter-born children were less likely to be dry post 
treatment. However, as indicated by the results of the Wald statistic = 1.48, p = .23, the 
slope coefficient was not statistically significant. 
The number of siblings in a family is unrelated to treatment outcome in children 
age 4. The group of 4-year-olds consisted of 16.4% (n =9) children without siblings, 
56.3% (n = 31) with one sibling, 18.2% (n =10) with two siblings, 7.3% (n = 4) with 
three siblings, and 1.8% (n = 1) with one sibling. The logistic regression analysis indicted 
a negative (B = -.322) logistic regression slope coefficient, suggesting that children with 
the least number of siblings were more likely to be dry post treatment compared to 
children with two or more siblings.  However, the Wald-statistic = 1.01, p = .23 indicated 
that the coefficient slope coefficient was not statistically significant. 
Family history of enuresis is a predictor for positive enuresis alarm treatment in 
children age 4. The group of 4–year-olds included 41.8% (n =23) children without a 
family history of enuresis and 58.2% (n =32) children with a family history of bedwetting 
defined as at least one of the following family members suffering or have suffered in the 
past from enuresis (i.e., father, mother, sibling, aunt, uncle, grandmother, or grandfather). 
The logistic regression slope for a family history of enuresis was positive (B = 1.201), 
indicating that a child with enuresis in the extended family was more likely to be dry post 
treatment compared to children without a family history of enuresis. Wald-statistic = 
4.35, p = .04 showed statistical significance of the logistic regression slope coefficient. 
To further understand the relationship between family history of enuresis and 
treatment outcomes, a cross-tabulation (see Table 1) and chi-square was employed to 
investigate the relative frequencies of treatment outcomes as a function of family history. 
The analysis showed that children age 4 with a family history of enuresis (71.9%) are 
more likely to be dry post treatment compared to children without family history of 
enuresis (43.5%). 
 
 
 
Table 1 
Cross-Tabulation of Genetic Predisposition and Treatment Outcome in 
4-Year-Old Children 
 
 
Treatment Outcome 
 Dry Wet 
No Family History 10 (43.5%) 13 (56.5%) 
 
Family History 
 
23 (71.9%) 
 
9  (28.1%) 
 
 
 
 
Age was unrelated to treatment outcome, indicated by similar treatment success 
rates of all age groups from the sample. Two different, yet complementary, statistical 
analyses  were  employed  in  support  of  this  finding.  First,  a  chi-square  test  of 
independence was used to test the relationship between age and treatment outcome 
variables. Second, ANOVA was utilized to compare mean success rates for all age 
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groups followed by a cross tabulation of the child’s age in years and treatment outcome 
was performed (see Table 2) to summarize these observations. The chi-square test of 
independence  analysis  found  no  statistical  evidence  that  the  treatment  effectiveness 
varied by age, 2 (3, n = 186) = .83, p = .84, v = .07. Overall, the percentage of children 
achieving post treatment dryness for the 4, 5, 6, and 7-year-olds was 60.0%, 66.7%, 
68.0%, and 64.4%, respectively. The results of the ANOVA analyses, that compared the 
mean success rates for all four treatment groups, found no statistical evidence that the 
post treatment success rates varied by age group F (3, 182) = 0.27, p = .85. 
 
 
 
Table 2 
Cross-Tabulation of Child’s Age and Treatment Outcome 
 
 
Child Age Treatment Outcome 
             in Years           Total N                        Dry (N/%)       Wet (N/%)                                
4.00 55 33 (43.5%) 22 (56.5%) 
 
5.00 
 
36 
 
24 (66.7%) 
 
12 (33.3%) 
 
6.00 
 
50 
 
34 (68.0%) 
 
16 (32.0%) 
 
7.00 
 
45 
 
29 (64.4%) 
 
16 (35.6%) 
 
 
 
 
Discussion 
Data analysis indicates that for 4-year-olds, the studied pretreatment variables of 
age, birth order, and number of children in the family did not predict treatment outcome. 
The findings replicate the results of earlier studies on the same pretreatment variables in 
older children (Dische et al., 1983; Jensen & Kirstensen, 2001). However, a positive 
family history of enuresis was found to be an important predictor of positive treatment 
outcome in 4-year-olds, with results indicating that the treatment was most successful in 
4-year-old children with a family history (72%) of bedwetting, while less effective for 
children age 4 without a family history (43.5%) of bedwetting. The reason for this 
discrepancy in treatment outcomes in 4-year-olds with or without a family history of 
bedwetting was not addressed in this study. 
Superior treatment outcomes for children with a positive family history of 
bedwetting may be linked to parental attitudes toward bedwetting and/or greater parental 
involvement and compliance with the treatment regiment. Parents who have first hand 
experience with the issue might better understand the impact that involuntary wetting can 
have on a child. Such a personal history might lead to a greater sensitivity to the child’s 
experience and encouragement for the child to comply with the treatment protocol. 
Essential to a positive treatment outcome is use of the urine alarm treatment 
consistently (i.e., each night) for a time period of 2 to 6 months (Gimpel & Warzak, 
1998). The length of the treatment regimen, combined with the demands of a nightly 
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routine, requires sustained motivation on the part of the child and his or her family. It is 
possible that parents who are familiar with the problem understand the significance of a 
positive treatment outcome and are therefore able to facilitate the child’s motivation to 
comply with the treatment regimen until dryness is achieved. 
Conversely, the marginal success rate for children without a family history of 
bedwetting might be related to the parent’s role in understanding the problem and 
importance of treatment compliance. Further, parents unfamiliar with the problem might 
assume that the child has at least some conscious control over his or her bladder function 
and that the child is either too lazy or simply not willing to exercise control. On the other 
hand, parents with a family history of bedwetting tend to know that bedwetting is not 
intentional nor can it be controlled through cognition, desire, wish fulfillment, or trying 
harder to remain dry. As indicated, the difference in parental first hand experience 
identified in this study suggests a number of implications for treating enuresis; e.g., 
focused parent education that addresses parental attitudes toward the disorder and the 
potential impact these feelings may have on treatment compliance, persistence, and 
consistency. 
While this analysis of the age related pretreatment variable indicated that age is 
not a predicator for urine alarm treatment outcomes in children age four, the study does 
suggest that the applied urine alarm treatment is similarly effective for children age 4 to 
age 7.  Current pediatric (Boris & Dalton, 2004) and psychiatric diagnostic guidelines 
(American Psychiatric Association [APA], 2000) require a minimum age of 5 years for a 
diagnosis of enuresis implying that the earliest start of urine alarm treatment is set at age 
5.   However, research indicates prolonged suffering from symptoms of bedwetting 
increases the probability for a child to develop behavioral and emotional problems 
(Fergusson  &  Horwood,  1994).  In  addition,  other  research  stipulates  only  a  6% 
probability for a 4-year-olds to become dry without intervention in the next year (Oppel, 
Harper, & Rider, 1968). 
In view of the implied limits on use of the urine alarm system to treat enuresis for 
children,  the  present  study  provides  some  evidence  that  urine  alarm  treatment  is 
successful for children age 4, especially for those who have a family history of this 
disorder. As a consequence of these findings, pediatricians and other health practitioners 
are encouraged to rethink treatment guidelines for bedwetting children and to offer urine 
alarm treatment to motivated parents with eneuretic 4-year-old children. 
Clinical implications for 4-year-olds without a family history of bedwetting are 
less clear. However, when confronted with the question of whether to start treating a 
child at age 4 with the urine alarm system, clinicians should take into consideration the 
finding that children without a family history of bedwetting have a 45% probability of 
success. While this probability is not as impressive as that for 4-year-old children with a 
family history of enuresis (i.e., 72% success rate), it does suggest the potential benefit of 
parent education about enuresis as a potentially effective strategy to increase parent 
sensitivity   to   the   causative   factors   to   childhood   enuresis.   With   a   heightened 
understanding and awareness of this information, parents without a personal history of 
enuresis may increase sensitivity to the child’s needs for support during treatment for 
bedwetting. 
Because this study was conducted in Israel through a single clinical psychologist, 
future research could explore the research questions across several practice settings; e.g., 
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outpatient pediatric urologic clinics, multiple pediatrician practice settings. In addition, 
study of enuresis treatment outcomes in additional culturally diverse populations would 
be  instructive.  Further  investigation  of  early  age  urine  alarm treatment  outcomes  in 
the United States with children as young as 4 years of age is warranted based upon these 
results. 
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